Free radicals in anticancer drug pharmacology

B K Sinha1

  • 1Clinical Pharmacology Branch, National Cancer Institute, Bethesda, MD 20892.

Insights

Certain antitumor drugs, like quinone antibiotics and etoposide, generate free radicals. These reactive intermediates damage tumor cells, impacting treatment effectiveness and resistance.

Area of Science:

  • Biochemistry
  • Pharmacology
  • Oncology

Background:

  • Free radical intermediates are implicated in the action of various antitumor agents.
  • Understanding their formation is crucial for cancer therapy.

Purpose of the Study:

  • To review the formation of free radical intermediates from clinically active antitumor agents.
  • To correlate free radical generation with tumor cell kill and resistance mechanisms.

Main Methods:

  • Examination of existing literature on antitumor agents like quinone-containing antibiotics and etoposide.
  • Review of detection methods for free radicals in biological systems, including Electron Spin Resonance (ESR) and spin-trapping techniques.

Main Results:

  • Antitumor drugs, including quinone antibiotics and etoposide, can generate free radical intermediates.
  • Free radical formation in tumor cells is influenced by cellular bioenvironments and metabolic pathways.
  • Detected free radicals in biological systems via ESR and spin-trapping techniques.

Conclusions:

  • Free radicals generated by certain antitumor drugs contribute to tumor cell death.
  • Damage to DNA, membranes, and enzymes by reactive species is a key mechanism of tumor cell kill.
  • Cellular factors influence the generation and detection of drug-induced free radicals, impacting therapeutic outcomes.

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Radical Autoxidation01:20

Radical Autoxidation

The oxidation of an organic compound in the presence of air or oxygen is called autoxidation. For example, cumene reacts with oxygen to form hydroperoxide. Autoxidation involves initiation, propagation, and termination steps. Many organic compounds are susceptible to autoxidation—especially ethers in the presence of oxygen, which form hydroperoxides. Even though this reaction is slow, old ether bottles contain small amounts of peroxide, which leads to laboratory explosions during ether...
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Bioactivation and Tissue Toxicity01:25

Bioactivation and Tissue Toxicity

Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...